«Genethics» and public health genomics

Det Juridiske Fakultet

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Standard

«Genethics» and public health genomics. / Niemiec, Emilia; Howard, Heidi Carmen.

Applied Genomics and Public Health. Elsevier, 2019. p. 243-257.

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Harvard

Niemiec, E & Howard, HC 2019, «Genethics» and public health genomics. in Applied Genomics and Public Health. Elsevier, pp. 243-257. https://doi.org/10.1016/B978-0-12-813695-9.00013-3

APA

Niemiec, E., & Howard, H. C. (2019). «Genethics» and public health genomics. In Applied Genomics and Public Health (pp. 243-257). Elsevier. https://doi.org/10.1016/B978-0-12-813695-9.00013-3

Vancouver

Niemiec E, Howard HC. «Genethics» and public health genomics. In Applied Genomics and Public Health. Elsevier. 2019. p. 243-257 https://doi.org/10.1016/B978-0-12-813695-9.00013-3

Author

Niemiec, Emilia ; Howard, Heidi Carmen. / «Genethics» and public health genomics. Applied Genomics and Public Health. Elsevier, 2019. pp. 243-257

Bibtex

@inbook{19cb12db153b4ca5a705049074f8723f,

title = "«Genethics» and public health genomics",

abstract = "In this chapter, we first reflect on approaches to public health, ethical positions on public health issues, and definitions of health. We subsequently present ethical, legal, and social issues in genetics and genomics, with particular attention to public health and the historical perspective. We then discuss the issues related to the implementation of genomic technologies in public health with focus on genomic sequencing used for diagnosis, screening, its applications in the context of reproductive technologies, and the potential use of genome editing technology in the germline. Our reflections indicate that to ensure the ethical use of genomic technologies in public health, we should be transparent about the limitations of these technologies, risks and uncertainties involved, stakeholders and their interests, including the most vulnerable who may be affected, and about the values guiding practice of public health genomics.",

keywords = "CRISPR-Cas9, ELSI, Eugenics, Genome editing, Genomic screening, Public health genomics, Whole-exome sequencing, Whole-genome sequencing",

author = "Emilia Niemiec and Howard, {Heidi Carmen}",

year = "2019",

month = jan,

day = "1",

doi = "10.1016/B978-0-12-813695-9.00013-3",

language = "English",

isbn = "9780128136966",

pages = "243--257",

booktitle = "Applied Genomics and Public Health",

publisher = "Elsevier",

}

RIS

TY - CHAP

T1 - «Genethics» and public health genomics

AU - Niemiec, Emilia

AU - Howard, Heidi Carmen

PY - 2019/1/1

Y1 - 2019/1/1

N2 - In this chapter, we first reflect on approaches to public health, ethical positions on public health issues, and definitions of health. We subsequently present ethical, legal, and social issues in genetics and genomics, with particular attention to public health and the historical perspective. We then discuss the issues related to the implementation of genomic technologies in public health with focus on genomic sequencing used for diagnosis, screening, its applications in the context of reproductive technologies, and the potential use of genome editing technology in the germline. Our reflections indicate that to ensure the ethical use of genomic technologies in public health, we should be transparent about the limitations of these technologies, risks and uncertainties involved, stakeholders and their interests, including the most vulnerable who may be affected, and about the values guiding practice of public health genomics.

AB - In this chapter, we first reflect on approaches to public health, ethical positions on public health issues, and definitions of health. We subsequently present ethical, legal, and social issues in genetics and genomics, with particular attention to public health and the historical perspective. We then discuss the issues related to the implementation of genomic technologies in public health with focus on genomic sequencing used for diagnosis, screening, its applications in the context of reproductive technologies, and the potential use of genome editing technology in the germline. Our reflections indicate that to ensure the ethical use of genomic technologies in public health, we should be transparent about the limitations of these technologies, risks and uncertainties involved, stakeholders and their interests, including the most vulnerable who may be affected, and about the values guiding practice of public health genomics.

KW - CRISPR-Cas9

KW - ELSI

KW - Eugenics

KW - Genome editing

KW - Genomic screening

KW - Public health genomics

KW - Whole-exome sequencing

KW - Whole-genome sequencing

UR - http://www.scopus.com/inward/record.url?scp=85093485155&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-813695-9.00013-3

DO - 10.1016/B978-0-12-813695-9.00013-3

M3 - Book chapter

AN - SCOPUS:85093485155

SN - 9780128136966

SP - 243

EP - 257

BT - Applied Genomics and Public Health

PB - Elsevier

ER -

ID: 369540428